Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Research

gene-sequencing_650x450
February 24, 2020/Cancer/Research

Researchers Validate Link Between Genetic Variant and Poor Outcomes in Advanced Prostate Cancer

Cleveland Clinic-led study lays groundwork for more personalized treatments

20-CNR-568_CQD_650x450_482145647
February 3, 2020/Cancer/Research

New Approach Leads to Transfusion Independence in Low-risk MDS

Luspatercept shows promise for patients with few options

19-CNR-5095 NCI grant 650×450
January 29, 2020/Cancer/Research

NCI Grant to Cleveland Clinic Scientist Will Support Evolution-Based Cancer Research

Searching for new insights into drug resistance, collateral sensitivity

19-CNR-6810 QD ASH Top 10 Twitter
January 23, 2020/Cancer/Research

Top 10 Takeaways from ASH 2019

These research results will have impact in 2020

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

18-CCC-5885-DNA-PTA-test-650×450
January 15, 2020/Cancer/Research

New Clinic Tackles Mutations That Increase Risk of Blood Cancers and Heart Disease

CHIP Clinic's goals: Research, preventive care

650×450-invasive-lobular-breast-cancer
December 12, 2019/Cancer/Research

No Survival Advantage from Chemo-endocrine Therapy over Endocrine Therapy in Invasive Lobular Carcinoma

Study suggests limited role for CET in this cancer type

QD-Follicular-Lymphoma-WINTER
December 9, 2019/Cancer/Research

Lenalidomide/Monoclonal Antibody Combination Superior to PI3K Inhibitor Monotherapy as First Novel Agent in Relapsed Follicular Lymphoma

Study assesses outcomes of therapies with novel agents

T-cells_650x450
December 9, 2019/Cancer/Research

Findings Suggest CAR T-Cell Therapy is Highly Effective for Relapsed/Refractory Mantle Cell Lymphoma

Autologous anti-CD19 agent produces impressive survival improvements

QD-Myelofibrosis-GERDS
December 9, 2019/Cancer/Research

Treatment for Myelofibrosis-Associated Anemia on the Horizon

Interim results of phase 2 trial are promising

AML
December 8, 2019/Cancer/Research

Studies’ Results Support Liberalization of Some Eligibility Criteria for Acute Myeloid Leukemia Clinical Trials

Overly restrictive exclusions may lead to racial disparities and unrealistic outcomes

BackPage 16 of 32Next

Advertisement

Ad